Try
Twist Bioscience Corporation Common Stock
TWSTUnited States
23 filed reports · 406 financial concepts · 1 earnings calls · 3 media appearances
Filed reports
23 reports · Jun 2021 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 1 operating metrics, 9 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 15 | 2,847 | Jun 2021 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 5 | 2,048 | Sep 2021 to Sep 2025 |
| Annual · 10-K/ASEC EDGAR | 1 | 458 | Sep 2022 |
| Current · 8-KSEC EDGAR | 1 | 9 | Jun 2026 |
| Quarterly · 10-Q/ASEC EDGAR | 1 | 244 | Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q3 | 10-Q | Jun 30, 2026 | Aug 3, 2026 | 415 | Open |
| FY2026 Q3 | 8-K | Jun 30, 2026 | Aug 3, 2026 | 9 | Open |
| FY2026 Q2 | 10-Q | Mar 31, 2026 | May 4, 2026 | 264 | Open |
| FY2026 Q1 | 10-Q/A | Dec 31, 2025 | Feb 26, 2026 | 244 | Open |
| FY2025 | 10-K | Sep 30, 2025 | Nov 17, 2025 | 864 | Open |
| FY2025 Q3 | 10-Q | Jun 30, 2025 | Aug 4, 2025 | 175 | Open |
| FY2025 Q2 | 10-Q | Mar 31, 2025 | May 5, 2025 | 158 | Open |
| FY2025 Q1 | 10-Q | Dec 31, 2024 | Feb 3, 2025 | 159 | Open |
| FY2024 | 10-K | Sep 30, 2024 | Nov 18, 2024 | 449 | Open |
| FY2024 Q3 | 10-Q | Jun 30, 2024 | Aug 2, 2024 | 187 | Open |
| FY2024 Q2 | 10-Q | Mar 31, 2024 | May 2, 2024 | 166 | Open |
| FY2024 Q1 | 10-Q | Dec 31, 2023 | Feb 2, 2024 | 171 | Open |
Financial data
406 concepts · 5,606 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial382 concepts · 5,221 facts · Sep 2019 to Jul 2026
- Cash cash equivalents restricted cash and restricted cash equivalents33 · Sep 2019 to Jun 2026
- Stockholders equity (US GAAP)33 · Sep 2019 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value32 · Sep 2019 to Jun 2026
- Allocated share based compensation expense32 · Sep 2019 to Jun 2026
- Comprehensive income net of tax32 · Sep 2019 to Jun 2026
- Cost of revenue (US GAAP)32 · Sep 2019 to Jun 2026
- Costs and expenses32 · Sep 2019 to Jun 2026
- Income tax expense benefit32 · Sep 2019 to Jun 2026
- Investment income interest32 · Sep 2019 to Jun 2026
- Net income loss32 · Sep 2019 to Jun 2026
- Operating income loss32 · Sep 2019 to Jun 2026
- Operating lease liability32 · Sep 2020 to Jun 2026
- Other comprehensive income loss foreign currency transaction and translation adjustment net of tax32 · Sep 2019 to Jun 2026
- Other comprehensive income loss net of tax32 · Sep 2019 to Jun 2026
- Other comprehensive income unrealized holding gain loss on securities arising during period net of tax32 · Sep 2019 to Jun 2026
- Other nonoperating income expense32 · Sep 2019 to Jun 2026
- Profit loss32 · Sep 2019 to Jun 2026
- Research and development expense32 · Sep 2019 to Jun 2026
- Revenue32 · Sep 2019 to Jun 2026
- Selling general and administrative expense32 · Sep 2019 to Jun 2026
- Stock issued during period value stock options exercised32 · Sep 2019 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect31 · Sep 2019 to Jun 2026
- Depreciation depletion and amortization31 · Sep 2019 to Jun 2026
- Effect of exchange rate on cash cash equivalents restricted cash and restricted cash equivalents31 · Sep 2019 to Jun 2026
Product1 concepts · 147 facts · Sep 2019 to Jun 2026
- Revenue147 · Sep 2019 to Jun 2026
Segment18 concepts · 130 facts · Sep 2023 to Jun 2026
- Costs and expenses10 · Sep 2023 to Jun 2026
- Depreciation depletion and amortization10 · Sep 2023 to Jun 2026
- Income tax expense benefit10 · Sep 2023 to Jun 2026
- Investment income interest10 · Sep 2023 to Jun 2026
- Net income loss10 · Sep 2023 to Jun 2026
- Operating income loss10 · Sep 2023 to Jun 2026
- Other nonoperating income expense10 · Sep 2023 to Jun 2026
- Reportable Segment10 · Sep 2023 to Jun 2026
- Revenue10 · Sep 2023 to Jun 2026
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest9 · Sep 2023 to Jun 2026
- Gain loss on sale of business6 · Sep 2023 to Jun 2026
- Share based compensation6 · Dec 2024 to Jun 2026
- Litigation settlement expense4 · Mar 2025 to Jun 2026
- Allocated share based compensation expense3 · Sep 2023 to Sep 2025
- Asset impairment charges3 · Sep 2023 to Sep 2025
- Change in fair value of contingent considerations and holdbacks3 · Sep 2023 to Sep 2025
- Cost of revenue (US GAAP)3 · Sep 2023 to Sep 2025
- Restructuring costs3 · Sep 2023 to Sep 2025
Geography1 concepts · 98 facts · Sep 2019 to Jun 2026
- Revenue98 · Sep 2019 to Jun 2026
Guidance3 concepts · 9 facts · Aug 2026
- Revenue Growth Guidance4 · Aug 2026
- Revenue Guidance4 · Aug 2026
- Gross Margin Guidance1 · Aug 2026
KPI1 concepts · 1 facts · Jun 2026
- Customer Count1 · Jun 2026
Segments
375 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service5 members · 147 facts
- Ngs Tools32 · Sep 2019 to Jun 2026
- Dna And Biopharma Libraries29 · Sep 2019 to Sep 2025
- Oligo Pools29 · Sep 2019 to Sep 2025
- Synthetic Genes29 · Sep 2019 to Sep 2025
- Antibody Discovery28 · Sep 2020 to Jun 2026
Statement business segments1 member · 130 facts
- Reportable130 · Sep 2023 to Jun 2026
Statement geographical4 members · 98 facts
- Americas32 · Sep 2019 to Jun 2026
- Asia Pacific32 · Sep 2019 to Jun 2026
- EMEA32 · Sep 2019 to Jun 2026
- US2 · Jun 2020 to Jun 2021
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary65 claims from 9 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary125 claims from 9 reports · Sep 2024 to Jun 2026
- Risk-factor changes21 claims from 1 reports · Sep 2025
- Risk factors120 risks from 2 annual reports · 2024 to 2025
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q3Aug 3, 2026
Executive media
3 appearancesPodcasts, interviews and conference appearances by the company's executives, with their claims.
- Other appearances2 · Jul 2021 to May 2023
- Conference talks1 · Jun 2022
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.